|
Harvey Herschman, Ph.D.
Contact Information:
Fax Number:
(310) 825-1447
Office Phone Number:
(310) 206-6003
(310) 825-8735
(310) 825-8745
Office Address:
Office 341 Boyer Hall (MBI), 611 Charles E. Young Drive East Los Angeles, CA 90095 UNITED STATES
Distinguished Professor,
Biological Chemistry
Molecular & Medical Pharmacology
|
Professor,
Institute for Molecular Medicine
|
Vice Chair,
Molecular & Medical Pharmacology
|
Member,
Cancer Molecular Imaging
CTSI
Crump Institute for Molecular Imaging
Molecular Biology Institute
|
Faculty,
Molecular Biology IDP
|
|
Awards and Honors:
Chair, Internal Advisory Board for UCLA-NCI Prostate SPORE program
Pfizer Visiting Professor, Yale University Medical School
Executive Advisory Board for UCLA-NCI Scholars in Oncologic Molecular Imaging Program
Israeli Cancer Research Foundation Award for Excellence in Scientific Research
Merck Visiting Professor, University of Connecticut Health Sciences
Member, ACCESS admissions committee
UCLA Faculty Research Lecture
UCLA Medical School Alumnae Award for Excellence in Scientific Research
Research Interest:
The role of prostaglandins and cycloxygenases in nomal physiology and disease; applications of molecular imaging
<p>Dr. Herschman's laboratory studies how extracellular stimuli elicit changes in cell growth and differentiation, as a result of induced transcription of "primary response" genes. One gene discovered by Dr. Herschman and his colleagues encodes a second form of cyclooxygenase (COX-2), the rate limiting enzyme in prostaglandin production and the target of a new generation of anti-inflammatory, anti-pyretic and analgesic pharmaceutical agents. The laboratory also identified synaptotagmin 4 as a depolarization-induced neuronal gene; a candidate for a mediator of depolarization-induced synaptic plasticity. Lastly, the laboratory has merged principles of cell biology, molecular biology and molecular imaging technologies to develop procedures that repetitively, non-invasively and quantitatively image reporter gene expression in intact, living animals. Current research interests center on improved therapies for colorectal cancer, and on the role of the COX-2 gene in the progression of a variety of epithelial cancers. </p>
<p> Dr. Herschman is Distinguished Professor in both the Department of Biological Chemistry and the Department of Molecular and Medical pharmacology. He holds the Ralph and Marjorie Crump Endowed Chair in Molecular Imaging. Dr. Herschman is the Director for Basic Research for the UCLA Jonsson Comprehensive Cancer Center, and the Principal Investigator for the UCLA in vivo Cellular and Molecular Imaging Center, a National Cancer Institute supported center for non-invasive imaging studies of cancer. He is a member of the Molecular Biology Institute, the CNSI and the Jonsson Comprehensive Cancer Center at UCLA.</p>
Detailed Biography:
Dr. Harvey Herschman received a B.A. from Rice University and a Ph.D. from the University of California at San Diego. After two years as a post doctoral fellow at Brandeis University, he joined the UCLA faculty as an Assistant Professor in the Department of Biological Chemistry in 1969 . He is currently Distinguished Professor in both the Department of Biological Chemistry and the Department of Molecular and Medical pharmacology. Dr. Herschman's laboratory discovered the COX-2 gene, and has been involved in studies on COX-2 induction, and in investigations of the role of COX-2 in normal biology and in the pathophysiologies of inflammation, neurodegeneration and cancer. He has also pioneered in the development and application of non-invasive, repeated and quantitative methods for molecular imaging of gene expression in living animals, and is the Director of UCLA's In Vivo Cellular and Molecular Imaging Center, funded by the National Cancer Institute.
Publications:
Tseng Han-Ching, Arasteh Aida, Paranjpe Avina, Teruel Antonia, Yang Wendy, Behel Armin, Alva Jackelyn A, Walter Gina, Head Christian, Ishikawa Tomo-o, Herschman Harvey R, Cacalano Nicholas, Pyle April D, Park No-Hee, Jewett Anahid
Increased lysis of stem cells but not their differentiated cells by
natural killer cells; de-differentiation or reprogramming activates NK
cells.
PloS one,
2010; 5(7):
e11590.
Toy Gerald, Austin Wayne R, Liao Hsiang-I, Cheng Donghui, Singh Arun, Campbell Dean O, Ishikawa Tomo-o, Lehmann Lynn W, Satyamurthy Nagichettiar, Phelps Michael E, Herschman Harvey R, Czernin Johannes, Witte Owen N, Radu Caius G
Requirement for deoxycytidine kinase in T and B lymphocyte
development.
Proceedings of the National Academy of Sciences of the United States of America,
2010; 107(12):
5551-6.
Johnson Stuart L, Franz Christoph, Kuhn Stephanie, Furness David N, Rüttiger Lukas, Münkner Stefan, Rivolta Marcelo N, Seward Elizabeth P, Herschman Harvey R, Engel Jutta, Knipper Marlies, Marcotti Walter
Synaptotagmin IV determines the linear Ca2+ dependence of vesicle
fusion at auditory ribbon synapses.
Nature neuroscience,
2010; 13(1):
45-52.
Lomenick Brett, Hao Rui, Jonai Nao, Chin Randall M, Aghajan Mariam, Warburton Sarah, Wang Jianing, Wu Raymond P, Gomez Fernando, Loo Joseph A, Wohlschlegel James A, Vondriska Thomas M, Pelletier Jerry, Herschman Harvey R, Clardy Jon, Clarke Catherine F, Huang Jing
Target identification using drug affinity responsive target stability
(DARTS).
Proceedings of the National Academy of Sciences of the United States of America,
2009; 106(51):
21984-9.
Koya Richard C, Kimura Takahiro, Ribas Antoni, Rozengurt Nora, Lawson Gregory W, Faure-Kumar Emmanuelle, Wang He-jing, Herschman Harvey, Kasahara Noriyuki, Stripecke Renata
Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.
Molecular therapy : the journal of the American Society of Gene Therapy,
2007; 15(5):
971-80.
Chikazu Daichi, Li Xiaodong, Kawaguchi Hiroshi, Sakuma Yoko, Voznesensky Olga S, Adams Douglas J, Xu Manshan, Hoshi Kazuto, Katavic Vedran, Herschman Harvey R, Raisz Lawrence G, Pilbeam Carol C
Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. 2002.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
2005; 20(10):
1888-98.
Singh Vinita, Miranda Tina Branscombe, Jiang Wei, Frankel Adam, Roemer Martha E, Robb Victoria A, Gutmann David H, Herschman Harvey R, Clarke Steven, Newsham Irene F
DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.
Oncogene,
2004; 23(47):
7761-71.
|
|